Kidney Gene Therapy
Kidney Gene Therapy - Related Videos
01:22
Gene Therapy
0 Views •
2021
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:22
Gene Therapy
0 Views •
2026
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
08:06
Isolation and Culture of Cells from the Nephrogenic Zone of the Embryonic Mouse Kidney
0 Views •
Cited by 20 •
2011
In this report we describe a method for the isolation and culture of the progenitor cell niche from the embryonic mouse kidney that can be used to study signaling pathways regulating stem/progenitor cells of the developing kidney. These cultured cells are highly accessible to small molecule and recombinant protein treatment, and importantly also to viral transduction, which allows efficient manipulation of candidate pathways.
08:19
The Mouse Isolated Perfused Kidney Technique
0 Views •
Cited by 24 •
2016
The mouse isolated perfused kidney (MIPK) is a technique for keeping a mouse kidney under ex vivo conditions perfused and functional for 1 hr. The buffers and surgical technique are described in detail.
07:40
Dissection of the Adult Zebrafish Kidney
0 Views •
Cited by 38 •
2011
The zebrafish kidney is home to both renal and hematopoietic adult stem/progenitor cells, and represents an outstanding opportunity to study these cell types and their progeny in a vertebrate model organism. Here, we demonstrate a detailed dissection procedure that enables the researcher to identify and surgically remove the adult zebrafish kidney, which can be used for applications such as cell isolation, transplantation, and expression studies of kidney and/or blood cell populations.
FAQs
The approach depends on delivering genetic material to kidney cells that contribute to the disease process. A functional gene may restore production of a missing or abnormal protein, while gene-editing components or regulatory sequences can alter disease-related gene activity. The intended result is a targeted change in cellular function rather than a general treatment of the entire body.
Viral and nonviral vectors provide alternative systems for transporting genetic material into kidney cells. Their use reflects a central delivery decision: researchers must match the transport system to the intended genetic cargo and target cells. The overview identifies both options but does not establish one as universally superior, so delivery efficiency and long-term safety remain important criteria.
These materials expand the possible actions beyond supplying a functional gene. Gene-editing components may be used to address harmful genetic changes, whereas regulatory sequences may modify abnormal gene activity. This distinction allows investigators to study whether a renal disorder is better approached by restoring protein production, changing signaling, or correcting the underlying mutation.
A treatment must reach relevant kidney cells sufficiently to produce the intended biological effect, making delivery efficiency a fundamental constraint. It must also remain acceptably safe over time, because genetic material or its effects may have lasting consequences. These challenges influence whether promising laboratory strategies can become precise treatments for renal disease.
Development begins by linking a renal disease mechanism to an appropriate genetic intervention, such as a functional gene, editing component, or regulatory sequence. Researchers then need a vector strategy capable of reaching target kidney cells and must examine whether the desired protein production or signaling change occurs. Delivery performance and longer-term safety guide further development.
The strongest areas identified for investigation include inherited kidney disorders, chronic kidney injury, and mechanisms of renal repair. In inherited disease, researchers can examine strategies related to harmful mutations; in chronic injury, they can study disease-related gene activity. The broader goal is to develop precision treatments while clarifying how renal cells respond to genetic intervention.
If delivery is effective and safety is sustained, genetic treatment could address disease mechanisms rather than relying only on supportive care. The overview connects this potential with reduced dependence on dialysis or transplantation. It also places kidney gene therapy within precision medicine, where the selected intervention is matched to a mutation or abnormal signaling pathway.